High-dose Cephalexin for Cellulitis (HI-DOCC)
Clinical trial NCT05852262 · COMPLETED
Trial details
- NCT number
- NCT05852262
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2026-04-05
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.